Renal Failure and Transplantation

Published on 27/02/2015 by admin

Filed under Pediatrics

Last modified 27/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1149 times

Chapter 118

Renal Failure and Transplantation

Acute Renal Failure

Overview: Acute renal failure is defined as a sudden loss of renal function that may be due to inadequate renal perfusion, renal cell injury, or obstruction to urine flow. Recently, the term “acute kidney injury” (AKI) has been proposed to replace the term acute renal failure and is gaining wide acceptance.1 AKI usually develops in hospitalized children as a result of systemic illness or its treatment and not from primary renal disease. The most common causes of AKI in children are renal ischemia, nephrotoxic drugs, and sepsis.2 Other important causes are listed in Box 118-1. AKI from any cause can lead to chronic kidney disease.37 Recovery of renal function depends on the underlying events leading to injury.

Intrinsic Renal Disease: Renal ischemia due to a prolonged prerenal injury or a severe hypoxic/ischemic insult can lead to acute tubular necrosis. Imaging findings depend on the severity of parenchymal injury. A generalized increase in renal cortical echogenicity indicates intrinsic renal disease (Fig. 118-1). In mild cases, the kidneys may appear normal or may demonstrate slightly increased renal cortical echogenicity. Decreased corticomedullary differentiation may be noted. Doppler flow may be normal in mild disease, whereas poor peripheral perfusion and diminished arterial diastolic flow due to increased peripheral vascular resistance occur in more severe cases.

Nephrotoxic drugs commonly associated with AKI include antibiotics, chemotherapeutic agents, and nonsteroidal antiinflammatory medications.8 Some agents such as aminoglycoside antibiotics cause tubular injury. Methicillin and other penicillin analogues, cimetidine, sulfonamides, rifampin, and nonsteroidal antiinflammatory drugs may cause acute interstitial nephritis, which is thought to be related to a hypersensitivity reaction with development of antitubular basement membrane antibodies in some cases. Children with acute lymphocytic leukemia and B-cell lymphoma are at risk for the development of uric acid nephropathy and tumor lysis syndrome. One mechanism of injury believed to be of importance in uric acid nephropathy is precipitation of uric acid crystals in the renal microvasculature leading to obstruction of renal blood flow, or precipitation in the renal tubules leading to obstruction of urine flow. Tumor lysis syndrome is a constellation of metabolic abnormalities resulting from spontaneous or treatment-related tumor necrosis. As tumor cells are lysed, rapid increases in serum potassium, uric acid, and phosphorus occur, with a decrease in serum calcium. Patients who are treated with allopurinol, a purine analog used to diminish the excretion of uric acid, instead excrete large quantities of the uric acid precursors xanthine and hypoxanthine. Precipitation of these compounds is thought to play a role in the development of AKI. In patients who are in septic shock, AKI can develop from hypotension, leading to renal ischemia and acute tubular necrosis, or AKI can develop as a result of the use of nephrotoxic medications.

Chronic Renal Failure

Overview: The terms “chronic renal failure” and “chronic renal insufficiency” have been used historically to describe varying degrees of renal dysfunction. Currently, the term chronic kidney disease (CKD) is used by both adult and pediatric nephrology communities throughout the world.11 The classification of CKD published by the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative is based on the estimated glomerular filtration rate and is applicable to children older than 2 years and to adults.12 The classification categorizes CKD into five different stages and is widely used in clinical practice (Table 118-1). Recently it has been recognized that most patients with CKD (estimated to be one in eight adults) never reach end-stage renal disease and the need for renal replacement therapy because they are at risk for accelerated cardiovascular disease and are more likely to die prematurely from cerebrovascular or cardiovascular disease.13 Therefore clinical management requires measures to diminish cardiovascular risk factors in both adult and pediatric patients. According to the North American Pediatric Renal Trials and Collaborative Studies 2007 report,14 the most common causes of pediatric CKD in North America are congenital disorders such as obstructive uropathy, renal dysplasia, and reflux nephropathy (Fig. 118-2; Table 118-2). In contrast, in Japan, 34% of pediatric CKD is due to glomerulonephritis, primary focal segmental glomerulosclerosis, and immunoglobulin A nephropathy.15 In Jordan16 and Iran,17 where consanguinity is more common, heritable disorders such as cystic kidney disease, primary hyperoxaluria, cystinosis, Alport syndrome, and congenital nephrotic syndrome represent a greater proportion of cases of CKD. In the developing world, acquired causes of CKD predominate, particularly infection-related glomerulopathies.18,19 The worldwide incidence and prevalence of CKD is greater for boys than for girls because of the higher incidence of congenital causes of CKD in boys.1421

Table 118-1

Kidney Disease Outcomes Quality Initiative Stages of Chronic Kidney Disease

Stage Description GFR (mL/min/1.73 m2)
1 Kidney damage with normal or increased GFR ≥90
2 Kidney damage with mild decrease in GFR 60-89
3 Moderate decrease in GFR 30-59
4 Severe decrease in GFR 15-29
5 Kidney failure <15 (or dialysis)

GFR, Glomerular filtration rate.

From VanDeVoorde RG, Warady BA. Management of chronic kidney disease. In: Avner ED, ed. Pediatric nephrology. 6th ed. Berlin: Springer-Verlag; 2009.

Table 118-2

Buy Membership for Pediatrics Category to continue reading. Learn more here